Top 5 deals of the first half of 2007

Deal-making continued at a blistering pace in the first half of 2007, as drug giants snapped up promising therapies from smaller developers in order to beef up their pipelines. See the companies below for a look at the biggest deals so far this year.

1. AstraZeneca and Bristol-Myers Squibb
2. Novartis and Antisoma
3. Shire and Renovo
4. Sanofi-Aventis and Oxford BioMedica
5. Amgen and Cytokinetics